Kонвулекс Хроно (Sodium Valproate)

Sodium Valproate, the active ingredient in Kонвулекс Хроно, is an anticonvulsant presented as an oral tablet for oral use. It treats generalized and focal seizures, manic episodes of bipolar disorder, and is used for migraine prophylaxis.

GNH USA supplies Kонвулекс Хроно as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sodium Valproate is employed in several neurological and psychiatric conditions where neuronal hyperexcitability is a key factor.

- Epilepsy: controls both generalized and focal seizures by stabilising neuronal membranes. - Bipolar disorder: reduces the frequency and severity of manic episodes through mood‑stabilising effects. - Migraine prophylaxis: decreases the number of migraine attacks when used as a preventive therapy.

Sodium Valproate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or gastrointestinal discomfort. - Weight gain or increased appetite. - Tremor or mild muscle twitching. - Drowsiness or fatigue. - Hair thinning or loss. - Transient rash.

Serious or Rare Side Effects: - Hepatic failure or severe liver enzyme elevation. - Acute pancreatitis. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome. - Blood dyscrasias including thrombocytopenia or agranulocytosis. - Hyperammonemic encephalopathy. - Severe coagulation abnormalities.

When prescribing Sodium Valproate, clinicians should observe several safety measures.

- Liver Monitoring: Perform baseline and periodic liver function tests, especially in the first six months. - Hematology Checks: Monitor complete blood counts to detect thrombocytopenia or leukopenia. - Pregnancy Risk: Avoid use in pregnancy unless no suitable alternative exists; discuss teratogenic risk. - Mitochondrial Disorders: Use with caution in patients with known mitochondrial disease. - Renal/Hepatic Impairment: Adjust dose or consider alternative therapy in significant organ dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Sodium Valproate interacts with several medicines that can alter its efficacy or increase toxicity.

Major Interactions (Avoid): - Carbamazepine, phenytoin or phenobarbital: may reduce valproate levels and increase seizure risk. - Other valproate-containing products: risk of additive toxicity. - Certain antiretrovirals (e.g., efavirenz): can lower valproate concentrations.

Moderate Interactions (Monitor Closely): - Aspirin and other NSAIDs: may increase bleeding risk by affecting platelet function. - Oral contraceptives: valproate can reduce contraceptive effectiveness; additional barrier methods are advised. - Warfarin: valproate may potentiate anticoagulant effect, requiring INR monitoring.